GL1X · GenesisL1 explorer

Research workbench

HIV integrase core domain in complex with inhibitor 3-methyl-2-{5- methyl-2-[2-(thiophen-2-YL)ETHYNYL]-1- benzofuran-3-YL}BUTANOIC acid

Analyse HIV integrase core domain in complex with inhibitor 3-methyl-2-{5… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6WE7
Type
protein
Length
133 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.-
UniProt
F2WR52
Ligands
TXM, SO4, IOD
Pockets
1 · best druggability 0.38

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrase (EC 2.7.7.-)protein13349% helix, 25% strandF2WR52

Ligands and binding sites

  • TXM · (2S)-3-methyl-2-{5-methyl-2-[(thiophen-2-yl)ethynyl]-1-benzofuran-3-yl}butanoic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · 5 copies · chains A
  • IOD · Iodide ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1930.380.7622SO4

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 6WE7 · HIV Integrase core domain in complex with inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.